Statistics

Total Visits

Views
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial 1093

Total Visits per Month

December 2025 January 2026 February 2026 March 2026 April 2026 May 2026 June 2026
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial 14 18 20 13 19 20 1

File Downloads

Views
Kyriazopoulou.pdf 495

Top Country Views

Views

Top City Views

Views